个人中心 - 老虎社区

lgnt

IP属地：未知

帖子 · 108帖子 · 108
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- lgntlgnt
  ·2021-11-02
  All good
  Bionano Genomics shares surged more than 10% in morning trading
  Bionano Genomics shares surged more than 10% in morning trading. Personalized medicine is the holy
  Bionano Genomics shares surged more than 10% in morning trading
  1,185 1
  5
  分享
  举报
- lgntlgnt
  ·2021-04-30
  Hopeful...
  679 评论
  1
  分享
  举报
- lgntlgnt
  ·2021-04-21
  Is this a good buy
  427 评论
  1
  分享
  举报
- lgntlgnt
  ·2021-04-20
  $FuelCell(FCEL)$Any goood?
  529 评论
  3
  分享
  举报
- lgntlgnt
  ·2021-04-19
  $Sundial Growers Inc.(SNDL)$Roller coaster
  886 2
  4
  分享
  举报
- lgntlgnt
  ·2021-04-18
  $FuelCell(FCEL)$Stay !
  1,644 4
  2
  分享
  举报
- lgntlgnt
  ·2021-04-17
  $FuelCell(FCEL)$Hopeful
  859 1
  4
  分享
  举报
- lgntlgnt
  ·2021-04-16
  $Gevo(GEVO)$Ouch
  731 评论
  1
  分享
  举报
- lgntlgnt
  ·2021-04-16
  Nice!
  911 评论
  点赞
  分享
  举报
- lgntlgnt
  ·2021-04-15
  Like n comment pls
  非常抱歉，此主贴已删除
  442 1
  6
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3575265409091533","uuid":"3575265409091533","gmtCreate":1612257345991,"gmtModify":1612967480609,"name":"lgnt","pinyin":"lgnt","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/1c510dc19933984119b9fc0dc1d30034","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":17,"headSize":77,"tweetSize":108,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.63%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.13%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":841060397,"gmtCreate":1635863462982,"gmtModify":1635863463128,"author":{"id":"3575265409091533","authorId":"3575265409091533","name":"lgnt","avatar":"https://static.tigerbbs.com/1c510dc19933984119b9fc0dc1d30034","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575265409091533","authorIdStr":"3575265409091533"},"themes":[],"htmlText":"All good","listText":"All good","text":"All good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/841060397","repostId":"1163085565","repostType":2,"repost":{"id":"1163085565","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635862319,"share":"https://www.laohu8.com/m/news/1163085565?lang=&edition=full","pubTime":"2021-11-02 22:11","market":"us","language":"en","title":"Bionano Genomics shares surged more than 10% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1163085565","media":"Tiger Newspress","summary":"Bionano Genomics shares surged more than 10% in morning trading.\n\nPersonalized medicine is the holy ","content":"<p>Bionano Genomics shares surged more than 10% in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/341f797630babaf15e0ae9aa0dbd5c7d\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Personalized medicine is the holy grail of biotech research. Despite numerous breakthroughs in the treatment of cancer with the advent of immunotherapy, a clinical success in this field is generally characterized by response rates as low as 30%. Researchers believe that these exceedingly low response rates stem from differences in the mutation type at both the nucleic acid and whole chromosomal level within a particular patient population. Cancer, in effect, is not a monolithic disease, making it impossible to develop a one-size-fits-all type of therapy.</p>\n<p>To boost the efficacy of these novel anti-cancer treatments, researchers thus require an accurate picture of the malignancy's genetic architecture at the individual level. That's where a company like Bionano Genomics comes into play. Bionano Genomicssportsa non-sequencing-based optical mapping technology known as the Saphyr System. The Saphyr System is designed to rapidly characterize extremely long strands of genomic DNA.</p>\n<p>What's more, the biotech recently acquired the leading genomics data analysis software company BioDiscovery. This landmark acquisition could turn out to be a game-changing business development move for the company and its shareholders. In brief, BioDiscovery's NXClinical software solution for variant analysis, combined with the Saphyr System, has the potential to accelerate the adoption of optical genome mapping at large. Moreover, this potentially best-in-class platform might ultimately grab an outsize portion of this multi-billion dollar market within the next few years.</p>\n<p>Bionano is slated to report third-quarter earnings on Nov. 4. While the biotech's Q3 revenue figure is unlikely to turn heads, investors should learn more about the long-term implications of this key acquisition. As a result, Bionano's beaten-down stock might finally start to show some signs of life after an eight-month downturn. Underscoring this point, the biotech's shares are currently down by a whopping 67% relative to their 52-week highs. Aggressive investors, in turn, may want to pick up some shares ahead of this upcoming earnings report.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bionano Genomics shares surged more than 10% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBionano Genomics shares surged more than 10% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-02 22:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Bionano Genomics shares surged more than 10% in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/341f797630babaf15e0ae9aa0dbd5c7d\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Personalized medicine is the holy grail of biotech research. Despite numerous breakthroughs in the treatment of cancer with the advent of immunotherapy, a clinical success in this field is generally characterized by response rates as low as 30%. Researchers believe that these exceedingly low response rates stem from differences in the mutation type at both the nucleic acid and whole chromosomal level within a particular patient population. Cancer, in effect, is not a monolithic disease, making it impossible to develop a one-size-fits-all type of therapy.</p>\n<p>To boost the efficacy of these novel anti-cancer treatments, researchers thus require an accurate picture of the malignancy's genetic architecture at the individual level. That's where a company like Bionano Genomics comes into play. Bionano Genomicssportsa non-sequencing-based optical mapping technology known as the Saphyr System. The Saphyr System is designed to rapidly characterize extremely long strands of genomic DNA.</p>\n<p>What's more, the biotech recently acquired the leading genomics data analysis software company BioDiscovery. This landmark acquisition could turn out to be a game-changing business development move for the company and its shareholders. In brief, BioDiscovery's NXClinical software solution for variant analysis, combined with the Saphyr System, has the potential to accelerate the adoption of optical genome mapping at large. Moreover, this potentially best-in-class platform might ultimately grab an outsize portion of this multi-billion dollar market within the next few years.</p>\n<p>Bionano is slated to report third-quarter earnings on Nov. 4. While the biotech's Q3 revenue figure is unlikely to turn heads, investors should learn more about the long-term implications of this key acquisition. As a result, Bionano's beaten-down stock might finally start to show some signs of life after an eight-month downturn. Underscoring this point, the biotech's shares are currently down by a whopping 67% relative to their 52-week highs. Aggressive investors, in turn, may want to pick up some shares ahead of this upcoming earnings report.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163085565","content_text":"Bionano Genomics shares surged more than 10% in morning trading.\n\nPersonalized medicine is the holy grail of biotech research. Despite numerous breakthroughs in the treatment of cancer with the advent of immunotherapy, a clinical success in this field is generally characterized by response rates as low as 30%. Researchers believe that these exceedingly low response rates stem from differences in the mutation type at both the nucleic acid and whole chromosomal level within a particular patient population. Cancer, in effect, is not a monolithic disease, making it impossible to develop a one-size-fits-all type of therapy.\nTo boost the efficacy of these novel anti-cancer treatments, researchers thus require an accurate picture of the malignancy's genetic architecture at the individual level. That's where a company like Bionano Genomics comes into play. Bionano Genomicssportsa non-sequencing-based optical mapping technology known as the Saphyr System. The Saphyr System is designed to rapidly characterize extremely long strands of genomic DNA.\nWhat's more, the biotech recently acquired the leading genomics data analysis software company BioDiscovery. This landmark acquisition could turn out to be a game-changing business development move for the company and its shareholders. In brief, BioDiscovery's NXClinical software solution for variant analysis, combined with the Saphyr System, has the potential to accelerate the adoption of optical genome mapping at large. Moreover, this potentially best-in-class platform might ultimately grab an outsize portion of this multi-billion dollar market within the next few years.\nBionano is slated to report third-quarter earnings on Nov. 4. While the biotech's Q3 revenue figure is unlikely to turn heads, investors should learn more about the long-term implications of this key acquisition. As a result, Bionano's beaten-down stock might finally start to show some signs of life after an eight-month downturn. Underscoring this point, the biotech's shares are currently down by a whopping 67% relative to their 52-week highs. Aggressive investors, in turn, may want to pick up some shares ahead of this upcoming earnings report.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1185,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":103241190,"gmtCreate":1619790234610,"gmtModify":1634209918613,"author":{"id":"3575265409091533","authorId":"3575265409091533","name":"lgnt","avatar":"https://static.tigerbbs.com/1c510dc19933984119b9fc0dc1d30034","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575265409091533","authorIdStr":"3575265409091533"},"themes":[],"htmlText":"Hopeful...","listText":"Hopeful...","text":"Hopeful...","images":[{"img":"https://static.tigerbbs.com/e6ae9c68d5839b6fefa86bd4e57b52a2","width":"750","height":"1607"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/103241190","isVote":1,"tweetType":1,"viewCount":679,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":378690826,"gmtCreate":1619019788365,"gmtModify":1634289153120,"author":{"id":"3575265409091533","authorId":"3575265409091533","name":"lgnt","avatar":"https://static.tigerbbs.com/1c510dc19933984119b9fc0dc1d30034","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575265409091533","authorIdStr":"3575265409091533"},"themes":[],"htmlText":"Is this a good buy","listText":"Is this a good buy","text":"Is this a good buy","images":[{"img":"https://static.tigerbbs.com/8202c161eede7f62a7ec37aedbde360c","width":"750","height":"2232"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/378690826","isVote":1,"tweetType":1,"viewCount":427,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":371809728,"gmtCreate":1618925200364,"gmtModify":1631886164392,"author":{"id":"3575265409091533","authorId":"3575265409091533","name":"lgnt","avatar":"https://static.tigerbbs.com/1c510dc19933984119b9fc0dc1d30034","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575265409091533","authorIdStr":"3575265409091533"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FCEL\">$FuelCell(FCEL)$</a>Any goood?","listText":"<a href=\"https://laohu8.com/S/FCEL\">$FuelCell(FCEL)$</a>Any goood?","text":"$FuelCell(FCEL)$Any goood?","images":[{"img":"https://static.tigerbbs.com/983cf47cb9308dc1ac1054067785b892","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/371809728","isVote":1,"tweetType":1,"viewCount":529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":373207497,"gmtCreate":1618846383719,"gmtModify":1634290406011,"author":{"id":"3575265409091533","authorId":"3575265409091533","name":"lgnt","avatar":"https://static.tigerbbs.com/1c510dc19933984119b9fc0dc1d30034","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575265409091533","authorIdStr":"3575265409091533"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>Roller coaster&nbsp;","listText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>Roller coaster&nbsp;","text":"$Sundial Growers Inc.(SNDL)$Roller coaster","images":[{"img":"https://static.tigerbbs.com/7c0fa29da6fa705db85b5ea6ee8feccf","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/373207497","isVote":1,"tweetType":1,"viewCount":886,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":379532213,"gmtCreate":1618759843932,"gmtModify":1631886164434,"author":{"id":"3575265409091533","authorId":"3575265409091533","name":"lgnt","avatar":"https://static.tigerbbs.com/1c510dc19933984119b9fc0dc1d30034","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575265409091533","authorIdStr":"3575265409091533"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FCEL\">$FuelCell(FCEL)$</a>Stay !","listText":"<a href=\"https://laohu8.com/S/FCEL\">$FuelCell(FCEL)$</a>Stay !","text":"$FuelCell(FCEL)$Stay !","images":[{"img":"https://static.tigerbbs.com/1f3d5bfe28a0b28ea475389d9c5d6a5d","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/379532213","isVote":1,"tweetType":1,"viewCount":1644,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":379989341,"gmtCreate":1618652770983,"gmtModify":1631886164435,"author":{"id":"3575265409091533","authorId":"3575265409091533","name":"lgnt","avatar":"https://static.tigerbbs.com/1c510dc19933984119b9fc0dc1d30034","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575265409091533","authorIdStr":"3575265409091533"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FCEL\">$FuelCell(FCEL)$</a>Hopeful","listText":"<a href=\"https://laohu8.com/S/FCEL\">$FuelCell(FCEL)$</a>Hopeful","text":"$FuelCell(FCEL)$Hopeful","images":[{"img":"https://static.tigerbbs.com/1f3d5bfe28a0b28ea475389d9c5d6a5d","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/379989341","isVote":1,"tweetType":1,"viewCount":859,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":370286965,"gmtCreate":1618586845957,"gmtModify":1631884126878,"author":{"id":"3575265409091533","authorId":"3575265409091533","name":"lgnt","avatar":"https://static.tigerbbs.com/1c510dc19933984119b9fc0dc1d30034","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575265409091533","authorIdStr":"3575265409091533"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GEVO\">$Gevo(GEVO)$</a>Ouch","listText":"<a href=\"https://laohu8.com/S/GEVO\">$Gevo(GEVO)$</a>Ouch","text":"$Gevo(GEVO)$Ouch","images":[{"img":"https://static.tigerbbs.com/53e8f76c29ba3f39d332576bd9b4cc11","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/370286965","isVote":1,"tweetType":1,"viewCount":731,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":370286034,"gmtCreate":1618586814028,"gmtModify":1634291892456,"author":{"id":"3575265409091533","authorId":"3575265409091533","name":"lgnt","avatar":"https://static.tigerbbs.com/1c510dc19933984119b9fc0dc1d30034","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575265409091533","authorIdStr":"3575265409091533"},"themes":[],"htmlText":"Nice!","listText":"Nice!","text":"Nice!","images":[{"img":"https://static.tigerbbs.com/e27683795216343a9fe892c59deeec90","width":"750","height":"2292"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/370286034","isVote":1,"tweetType":1,"viewCount":911,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":347671577,"gmtCreate":1618495142799,"gmtModify":1634292547817,"author":{"id":"3575265409091533","authorId":"3575265409091533","name":"lgnt","avatar":"https://static.tigerbbs.com/1c510dc19933984119b9fc0dc1d30034","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575265409091533","authorIdStr":"3575265409091533"},"themes":[],"htmlText":"Like n comment pls","listText":"Like n comment pls","text":"Like n comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/347671577","repostId":"1125635474","repostType":4,"isVote":1,"tweetType":1,"viewCount":442,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}